Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

Newly made nicotinamide compounds could potentially treat cancer.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

The man likely has secondary syphilis affecting his nervous system.

An elderly Chinese man lost all his hair after taking a new heart medication.

Bedaquiline, Telmisartan, Diosmin, Azelastine, and Adapalene may be effective treatments for onchocerciasis.

A fungal infection was successfully treated with oral and topical antifungals after being misdiagnosed and worsened by corticosteroids.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Hepatitis C treatment may trigger complete hair loss, especially in those with a history of patchy hair loss, but hair usually grows back within a year.

Pranlukast and mirabegron may work as new diabetes drugs.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Some natural compounds from Iris plants can block enzymes related to certain disorders, with a few affecting both targeted enzymes.

Upadacitinib successfully treated a child's severe skin and hair loss issues.

Upadacitinib effectively treats psoriasis and lichen planus together.

IVL-DrugFluidic® can mass-produce high-quality, long-acting injectable drug microspheres, improving patient compliance and reducing side effects.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

Finasteride helps reduce pain and inflammation in animals.

Securinine and ajmaline may effectively treat liver cancer, with securinine being less toxic to normal cells.

A prostate cancer drug can lower the levels of a protein that the coronavirus uses to enter lung cells.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Sintilimab treatment caused hair loss but led to complete tumor remission.